Seeking biomarkers in the 'salivaome'; Probe technology selected for European biomarker project;

> Collecting saliva is as simple as spitting into a pot, and an international research team is looking to use saliva biomarkers to create completely noninvasive diagnostic tests for a range of oral and systemic diseases. Press release | Article

> Probe Scientific's MicroEye in vivo sampling technology has been selected to be used in a major new European biomarker research project; the €5.2 million ($6.7 million) project will develop MicroEye for monitoring the efficacy of immunosuppressant drugs to prevent rejection post transplantation. Press release

> Isolated cancer cells could help select the best treatment in prostate cancer. Press release | Abstract

> Gene variants for breast density could influence breast cancer risk. Press release

> Ariosa Diagnostics has launched its Harmony Prenatal Test in the U.K., which screens for fetal trisomies using cell-free DNA in maternal blood. Press release

And Finally… Placebo responses could be in your genes. Researchers have identified genetic markers for the placebo response in irritable bowel syndrome. Abstract | Press release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.